Independent Study Utilizing Cyclic Levulan PDT Finds 95 Percent Reduction In New Squamous Cell Carcinoma Lesions In Solid Organ Transplant Recipients
The results of an independent investigator study just published in the online version of Dermatologic Surgery demonstrate that Levulan(®) Photodynamic Therapy (PDT) may reduce the rate of recurrence of squamous cell carcinomas (SCCs) in solid organ transplant recipients (SOTRs), a population with a high incidence of nonmelanoma skin cancer.